跳至主要内容
临床试验/NCT00448110
NCT00448110已完成3 期

Randomized, Double-Blind, Active- and Placebo-Controlled Study of the Efficacy and Safety of Repeated Dosing of DIC075V Relative To Parenteral Ketorolac and Placebo in Patients With Acute Post-Op Pain After Abdominal or Pelvic Surgery

Javelin Pharmaceuticals13 个研究点 分布在 1 个国家目标入组 331 人开始时间: 2006年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
331
试验地点
13
主要终点
Sum of the pain intensity differences (SPID) over the 0-48 hour time interval.

研究概览

简要总结

This study will compare repeated intermittent IV dosing of diclofenac in patients with moderate to severe post-surgical pain from abdominal or pelvic surgery.

详细描述

The primary objective is to evaluate the efficacy and safety of two dosage levels of parenteral diclofenac in providing pain relief as compared to placebo or Ketorolac tromethamine.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Scheduled within two weeks of the screening visit to undergo abdominal or pelvic surgery
  • Moderate to severe pain within 6 hours following completion of the required surgery.

排除标准

  • Surgical procedure involves a subcostal incision.
  • Chronic disease or recent cardiovascular events.
  • Known allergy or hypersensitivity to the active compounds or any of the excipients used in the study.
  • Additional Inclusion/Exclusion Criteria May Apply

研究组 & 干预措施

A

Experimental

intravenous diclofenac dosage level 1

干预措施: Intravenous Diclofenac (DIC075V) (Drug)

B

Experimental

intravenous diclofenac dosage level 2

干预措施: Intravenous Diclofenac (DIC075V) (Drug)

C

Active Comparator

intravenous ketorolac

干预措施: Intravenous Ketorolac (Drug)

D

Placebo Comparator

placebo

干预措施: placebo (Drug)

结局指标

主要结局

Sum of the pain intensity differences (SPID) over the 0-48 hour time interval.

时间窗: 0-48 hours

次要结局

  • SPID over the 0-24 hour interval(0-24 hours)
  • Other measures of pain relief(Multiple)

研究者

发起方
Javelin Pharmaceuticals
申办方类型
Industry

研究点 (13)

Loading locations...

相似试验